Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

L. Bjørge · SciRah

Researcher profile · Semantic Scholar

L. Bjørge

Share profile

L. Bjørge — researcher profile on SciRah

h-index: 36
Works: 138
Citations: 5,966

Most-cited papers

Identification of twelve new susceptibility loci for different histotypes of epithelial ovarian cancer
C. Phelan, Karoline B. Kuchenbaecker, J. Tyrer, S. Kar +410 more
2017Nature Genetics399 citations Open access
Semantic Scholar
Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial.
M. Mirza, E. Åvall Lundqvist, M. Birrer, René dePont Christensen +15 more
2019The Lancet Oncology224 citations Open access
Semantic Scholar
Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial.
A. du Bois, G. Kristensen, I. Ray-Coquard, A. Reuss +23 more
2016The Lancet Oncology202 citations Open access
Semantic Scholar
Overall Survival in Patients with Endometrial Cancer Treated with Dostarlimab plus Carboplatin-Paclitaxel in the Randomized ENGOT-EN6/GOG-3031/RUBY Trial.
M. Powell, L. Bjørge, L. Willmott, Z. Novak +27 more
2024Annals of Oncology132 citations Open access
Semantic Scholar
Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study.
Jue-Sheng Ong, G. Cuéllar-Partida, Yi Lu, P. Fasching +107 more
2016International Journal of Epidemiology114 citations Open access
Semantic Scholar
Shared heritability and functional enrichment across six solid cancers
Xia Jiang, H. Finucane, F. Schumacher, S. Schmit +329 more
2019Nature Communications104 citations Open access
Semantic Scholar
Preoperative tumor texture analysis on MRI predicts high‐risk disease and reduced survival in endometrial cancer
Sigmund Ytre-Hauge, J. Dybvik, A. Lundervold, Ø. Salvesen +8 more
2018Journal of Magnetic Resonance Imaging104 citations Open access
Semantic Scholar
BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers.
Huong D. Meeks, Hong-Lin Song, K. Michailidou, M. Bolla +249 more
2016Journal of the National Cancer Institute82 citations Open access
Semantic Scholar
A transcriptome-wide association study among 97,898 women to identify candidate susceptibility genes for epithelial ovarian cancer risk
Ying-Chang Lu, A. Beeghly-Fadiel, Lang Wu, Xing-Yi Guo +140 more
2018Cancer Research62 citations Open access
Semantic Scholar
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer
C. Phelan, K. Kuchenbaecker, J. Tyrer, S. Kar +410 more
2017Nature Genetics62 citations Open access
Semantic Scholar
Polygenic risk modeling for prediction of epithelial ovarian cancer risk
E. Dareng, J. Tyrer, D. Barnes, Michelle R. Jones +263 more
2022European Journal of Human Genetics57 citations Open access
Semantic Scholar
Patient-derived organoids reflect the genetic profile of endometrial tumors and predict patient prognosis
H. Berg, M. Hjelmeland, Hilde E. Lien, Heidi Espedal +11 more
2021Communications Medicine48 citations Open access
Semantic Scholar
Genetic data from nearly 63,000 women of European descent predicts DNA methylation biomarkers and epithelial ovarian cancer risk
Yaohua Yang, Lang Wu, Xiang Shu, Ying-Chang Lu +96 more
2018Cancer Research47 citations Open access
Semantic Scholar
A Simple Cervicovaginal Epigenetic Test for Screening and Rapid Triage of Women With Suspected Endometrial Cancer: Validation in Several Cohort and Case/Control Sets
Chiara M. S. Herzog, F. Marín, Allison Jones, I. Evans +27 more
2022Journal of Clinical Oncology46 citations Open access
Semantic Scholar
Final results from GCIG/ENGOT/AGO‐OVAR 12, a randomised placebo‐controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer
I. Ray-Coquard, D. Cibula, M. Mirza, A. Reuss +20 more
2019International Journal of Cancer45 citations Open access
Semantic Scholar
Preoperative quantitative dynamic contrast-enhanced MRI and diffusion-weighted imaging predict aggressive disease in endometrial cancer
K. Fasmer, A. Bjørnerud, Sigmund Ytre-Hauge, R. Grüner +7 more
2018Acta Radiologica45 citations
Semantic Scholar
High degree of heterogeneity of PD-L1 and PD-1 from primary to metastatic endometrial cancer.
H. Engerud, H. Berg, M. Myrvold, M. K. Halle +5 more
2020Gynecologic Oncology43 citations Open access
Semantic Scholar
Expression of L1CAM in curettage or high L1CAM level in preoperative blood samples predicts lymph node metastases and poor outcome in endometrial cancer patients
I. L. Tangen, R. Kopperud, N. Visser, A. Staff +9 more
2017British Journal of Cancer41 citations Open access
Semantic Scholar
Palbociclib plus letrozole in estrogen receptor-positive advanced/recurrent endometrial cancer: Double-blind placebo-controlled randomized phase II ENGOT-EN3/PALEO trial.
M. Mirza, L. Bjørge, F. Marmé, R. D. Christensen +16 more
2024Gynecologic Oncology34 citations Open access
Semantic Scholar
A national, prospective observational study of first recurrence after primary treatment for gynecological cancer in Norway
I. Vistad, L. Bjørge, O. Solheim, Bent Fiane +9 more
2017Acta Obstetricia et Gynecologica Scandinavica33 citations Open access
Semantic Scholar
Influence of p53 Isoform Expression on Survival in High-Grade Serous Ovarian Cancers
Katharina Bischof, S. Knappskog, S. Hjelle, I. Stefansson +4 more
2019Scientific Reports27 citations Open access
Semantic Scholar
Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regions.
E. Dareng, Simon G. Coetzee, J. Tyrer, Pei-Chen Peng +149 more
2024American Journal of Human Genetics24 citations Open access
Semantic Scholar
CD24-targeted intraoperative fluorescence image-guided surgery leads to improved cytoreduction of ovarian cancer in a preclinical orthotopic surgical model
K. Kleinmanns, V. Fosse, B. Davidson, Elvira García de Jalón +3 more
2020EBioMedicine23 citations Open access
Semantic Scholar
Divergent Regulation of Decidual Oxidative-Stress Response by NRF2 and KEAP1 in Preeclampsia with and without Fetal Growth Restriction
S. Mundal, J. Rakner, G. Silva, L. Gierman +10 more
2022International Journal of Molecular Sciences22 citations Open access
Semantic Scholar
A phase I study of the PARP inhibitor niraparib in combination with bevacizumab in platinum-sensitive epithelial ovarian cancer: NSGO AVANOVA1/ENGOT-OV24
M. Mirza, T. Bergmann, M. Mau-Sørensen, R. Christensen +10 more
2019Cancer Chemotherapy and Pharmacology21 citations
Semantic Scholar
High expression of the p53 isoform γ is associated with reduced progression-free survival in uterine serous carcinoma
Katharina Bischof, S. Knappskog, I. Stefansson, E. McCormack +5 more
2018BMC Cancer21 citations Open access
Semantic Scholar
TP53 mutation and human papilloma virus status as independent prognostic factors in a Norwegian cohort of vulva squamous cell carcinoma
H. Dongre, R. Elnour, S. Tornaas, S. Fromreide +7 more
2023Acta Obstetricia et Gynecologica Scandinavica18 citations Open access
Semantic Scholar
Efficient CAR T cell targeting of the CA125 extracellular repeat domain of MUC16
N. Casey, K. Kleinmanns, C. Forcados, P. Gelebart +17 more
2024Journal for ImmunoTherapy of Cancer17 citations Open access
Semantic Scholar
Final survival analysis of NSGO-AVANOVA2/ENGOT-OV24: Combination of niraparib and bevacizumab versus niraparib alone as treatment of recurrent platinum-sensitive ovarian cancer—A randomized controlled chemotherapy-free study.
M. Mirza, G. Nyvang, B. Lund, R. Christensen +16 more
202017 citations Open access
Semantic Scholar
Pan-carcinoma sialyl-Tn-targeting expands CAR therapy to solid tumors
R. Abrantes, C. Forcados, David J. Warren, L. Santos-Ferreira +19 more
2025Cell Reports Medicine16 citations Open access
Semantic Scholar
CD24-targeted fluorescence imaging in patient-derived xenograft models of high-grade serous ovarian carcinoma
K. Kleinmanns, Katharina Bischof, Shamundeeswari Anandan, M. Popa +6 more
2020EBioMedicine16 citations Open access
Semantic Scholar
Comparison of Five Near-Infrared Fluorescent Folate Conjugates in an Ovarian Cancer Model
Elvira García de Jalón, K. Kleinmanns, V. Fosse, B. Davidson +3 more
2021Molecular Imaging and Biology15 citations Open access
Semantic Scholar
Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study
S. Dixon-Suen, C. Nagle, A. Thrift, P. Pharoah +116 more
2018British Journal of Cancer15 citations Open access
Semantic Scholar
IMPRESS-Norway: improving public cancer care by implementing precision medicine in Norway; inclusion rates and preliminary results
K. Puco, G. L. Fagereng, S. Brabrand, P. Niehusmann +20 more
2024Acta oncologica14 citations Open access
Semantic Scholar
NSGO-OV-UMB1/ENGOT-OV30: A phase II study of durvalumab in combination with the anti-CD73 monoclonal antibody Oleclumab in patients with relapsed ovarian cancer.
M. Mirza, L. Tandaric, J. Henriksen, J. Mäenpää +10 more
2024Gynecologic Oncology14 citations Open access
Semantic Scholar
C77G in PTPRC (CD45) is no risk allele for ovarian cancer, but associated with less aggressive disease
Johannes Landskron, S. M. Kraggerud, E. Wik, A. Dørum +7 more
2017PLoS ONE14 citations Open access
Semantic Scholar
Fluorochrome Selection for Imaging Intraoperative Ovarian Cancer Probes
M. Perrone, P. Vitale, Morena Miciaccia, S. Ferorelli +8 more
2022Pharmaceuticals13 citations Open access
Semantic Scholar
The Emerging Role of CD24 in Cancer Theranostics—A Novel Target for Fluorescence Image-Guided Surgery in Ovarian Cancer and Beyond
K. Kleinmanns, V. Fosse, L. Bjørge, E. McCormack
2020Journal of Personalized Medicine13 citations Open access
Semantic Scholar
In vivo MR spectroscopy predicts high tumor grade in endometrial cancer
Sigmund Ytre-Hauge, Morteza Esmaeili, T. E. Sjøbakk, R. Grüner +9 more
2018Acta Radiologica13 citations
Semantic Scholar
Decidual and placental NOD1 is associated with inflammation in normal and preeclamptic pregnancies.
J. Rakner, G. Silva, S. Mundal, A. J. Thaning +6 more
2021Placenta12 citations Open access
Semantic Scholar
Combination of niraparib and bevacizumab versus niraparib alone as treatment of recurrent platinum-sensitive ovarian cancer: A randomized controlled chemotherapy-free study—NSGO-AVANOVA2/ENGOT-OV24.
M. Mirza, E. Åvall-Lundqvist, M. Birrer, R. Christensen +16 more
2019Journal of Clinical Oncology12 citations
Semantic Scholar
Proteomic profiling of endometrioid endometrial cancer reveals differential expression of hormone receptors and MAPK signaling proteins in obese versus non-obese patients
K. Mauland, Z. Ju, I. L. Tangen, A. Berg +9 more
2017OncoTarget12 citations Open access
Semantic Scholar
Late-week surgical treatment of endometrial cancer is associated with worse long-term outcome: Results from a prospective, multicenter study
Tormund Njølstad, H. M. Werner, J. Marcickiewicz, S. Tingulstad +10 more
2017PLoS ONE12 citations Open access
Semantic Scholar
CA-125 Levels Are Predictive of Survival in Low-Grade Serous Ovarian Cancer—A Multicenter Analysis
C. Wohlmuth, Vladimir Djedovic, S. Kjaer, A. Jensen +25 more
2022Cancers11 citations Open access
Semantic Scholar
Near-Infrared Fluorescent Imaging for Monitoring of Treatment Response in Endometrial Carcinoma Patient-Derived Xenograft Models
Tina Fonnes, E. Strand, K. Fasmer, H. Berg +7 more
2020Cancers11 citations Open access
Semantic Scholar
Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility
Madalene Earp, J. Tyrer, S. Winham, Hui-Yi Lin +145 more
2018PLoS ONE11 citations Open access
Semantic Scholar
Systems epigenetic approach towards non-invasive breast cancer detection
Chiara M. S. Herzog, Bente Theeuwes, Allison Jones, I. Evans +7 more
2025Nature Communications10 citations Open access
Semantic Scholar
Humanized Ovarian Cancer Patient-Derived Xenografts for Improved Preclinical Evaluation of Immunotherapies
K. Kleinmanns, Stein-Erik Gullaksen, G. Bredholt, B. Davidson +4 more
2022Cancers9 citations Open access
Semantic Scholar
953PA phase 1 study to evaluate the safety and tolerability of bevacizumab-niraparib combination therapy and determine the recommended phase 2 dose (RP2D) in women with platinum-sensitive epithelial ovarian cancer (ENGOT-OV24/AVANOVA1)
M. Mirza, Jiu-Zhou Wang, M. Mau-Sørensen, M. Birrer +12 more
20179 citations Open access
Semantic Scholar
Preoperative imaging markers and PDZ-binding kinase tissue expression predict low-risk disease in endometrial hyperplasias and low grade cancers
A. Berg, Ankush Gulati, Sigmund Ytre-Hauge, K. Fasmer +15 more
2017OncoTarget9 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

F. Modugno×12
Invite
F. Modugno — researcher profile on SciRah
A. Berchuck×12
Invite
A. Berchuck — researcher profile on SciRah
E. Goode×12
Invite
E. Goode — researcher profile on SciRah
H. Anton-Culver×11
Invite
H. Anton-Culver — researcher profile on SciRah

×11

Invite

R. Bützow — researcher profile on SciRah

Invite

T. Dörk — researcher profile on SciRah

J. Gronwald×11

Invite

J. Gronwald — researcher profile on SciRah

Invite

B. Karlan — researcher profile on SciRah

L. Kiemeney×11

Invite

L. Kiemeney — researcher profile on SciRah

D. Lambrechts×11

Invite

D. Lambrechts — researcher profile on SciRah

Invite

K. Moysich — researcher profile on SciRah

Invite

T. Pejovic — researcher profile on SciRah